Development of OX40 agonists for canine cancer immunotherapy.
Ruiz D, Haynes C, Marable J, Pundkar C, Nance RL, Bedi D, Agarwal P, Suryawanshi AS, Mishra A, Smith BF, Sandey M.
Ruiz D, et al. Among authors: agarwal p.
iScience. 2022 Sep 20;25(10):105158. doi: 10.1016/j.isci.2022.105158. eCollection 2022 Oct 21.
iScience. 2022.
PMID: 36217551
Free PMC article.